NO20031754L - Fremgangsmåte for fremstilling av mesylater av piperzinderivater - Google Patents

Fremgangsmåte for fremstilling av mesylater av piperzinderivater

Info

Publication number: NO20031754L
Authority: NO; Norway
Prior art keywords: mesylates; preparation; piperazine derivatives; piperazine; derivatives
Prior art date: 2001-02-16

Application number

NO20031754A

Other languages

English (en)

Other versions

NO324460B1 (no

NO20031754D0 (no

Inventor

Marcel P M Van Aar

Stefanus J Schouten

Jan Zorgdrager

Michiel C Heslinga

Original Assignee

Solvay Pharm Bv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-02-16

Filing date

2003-04-15

Publication date

2003-04-15

2003-04-15 Application filed by Solvay Pharm Bv filed Critical Solvay Pharm Bv

2003-04-15 Publication of NO20031754L publication Critical patent/NO20031754L/no

2003-04-15 Publication of NO20031754D0 publication Critical patent/NO20031754D0/no

2007-10-22 Publication of NO324460B1 publication Critical patent/NO324460B1/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
- C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
- C07D263/58—Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Neurology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Biomedical Technology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Psychiatry (AREA)
Pharmacology & Pharmacy (AREA)
Neurosurgery (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Plural Heterocyclic Compounds (AREA)

NO20031754A 2001-02-16 2003-04-15 Fremgangsmate for fremstilling av mesylater av piperazinderivater NO324460B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP01200534		2001-02-16
PCT/EP2002/001666 WO2002066449A2 (en)	2001-02-16	2002-02-14	Process for the preparation of mesylates of piperazine derivatives

Publications (3)

Publication Number	Publication Date
NO20031754L true NO20031754L (no)	2003-04-15
NO20031754D0 NO20031754D0 (no)	2003-04-15
NO324460B1 NO324460B1 (no)	2007-10-22

Family

ID=8179894

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20031754A NO324460B1 (no)	2001-02-16	2003-04-15	Fremgangsmate for fremstilling av mesylater av piperazinderivater

Country Status (35)

Country	Link
US (1)	US7030241B2 (no)
EP (1)	EP1362040B1 (no)
JP (1)	JP4328528B2 (no)
KR (2)	KR101000733B1 (no)
CN (1)	CN1176079C (no)
AR (1)	AR034206A1 (no)
AT (1)	ATE284875T1 (no)
AU (1)	AU2002250962B2 (no)
BG (1)	BG66101B1 (no)
BR (1)	BR0205683A (no)
CA (1)	CA2422703C (no)
CZ (1)	CZ301780B6 (no)
DE (1)	DE60202261T2 (no)
DK (1)	DK1362040T3 (no)
DZ (1)	DZ3489A1 (no)
ES (1)	ES2230481T3 (no)
HK (1)	HK1059934A1 (no)
HR (1)	HRP20030610B1 (no)
HU (1)	HUP0400772A3 (no)
IL (1)	IL153509A (no)
IS (1)	IS2417B (no)
ME (1)	MEP37508A (no)
MX (1)	MXPA03002359A (no)
MY (1)	MY130687A (no)
NO (1)	NO324460B1 (no)
NZ (1)	NZ524632A (no)
PL (1)	PL208363B1 (no)
PT (1)	PT1362040E (no)
RS (1)	RS51126B (no)
RU (1)	RU2272036C2 (no)
SI (1)	SI1362040T1 (no)
SK (1)	SK286143B6 (no)
UA (1)	UA75390C2 (no)
WO (1)	WO2002066449A2 (no)
ZA (1)	ZA200301590B (no)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7435738B2 (en)	2003-08-18	2008-10-14	Solvay Pharmaceuticals, Inc.	Stable crystalline form of bifeprunox mesylate (7-[4-([1,1′-biphenyl]-3-ylmethyl)-1-piperazinyl]-2(3H)-benzoxazolone monomethanesulfonate)
AR045362A1 (es) *	2003-08-18	2005-10-26	Solvay Pharm Bv	Forma cristalina estable de mesilato de bifeprunox (monometansulfonato de 7-[4-([1,1- bifenil] -3- ilmetil) -1- piperazinil] - 2-(3h) -benzoxazolona
US7405216B2 (en) *	2004-08-18	2008-07-29	Solvay Pharmaceuticals, B.V.	Stable crystalline form of bifeprunox mesylate (7-[4-([1,1′-biphenyl]-3-ylmethyl)-1-piperazinyl]-2(3H)-benzoxazolone monomethanesulfonate)
US7964604B2 (en) *	2005-02-18	2011-06-21	Solvay Pharmaceuticals B.V.	Bifeprunox mesylate maintenance dose compositions and methods for using the same
US7423040B2 (en) *	2005-02-18	2008-09-09	Irene Eijgendaal	Stable crystalline form of bifeprunox mesylate, dosage forms thereof and methods for using same
US20070275977A1 (en) *	2006-05-02	2007-11-29	Van Aar Marcel P	N-oxides of pyridylmethyl -piperazine and -piperidine derivatives
US7786126B2 (en) *	2006-06-16	2010-08-31	Solvay Pharmaceuticals B.V.	Combination preparations comprising SLV308 and a dopamine agonist
US8106056B2 (en)	2006-06-16	2012-01-31	Solvay Pharmaceuticals B.V.	Combination preparations comprising bifeprunox and a dopamine agonist
US20080132520A1 (en) *	2006-08-31	2008-06-05	Winsemius Antje A	Compositions, kits and methods for administering a titration schedule comprising bifeprunox compounds
BRPI0715445A2 (pt)	2006-08-31	2014-05-13	Solvay Pharm Bv	Uso de um composto de bifeprunox, e, kit de titulação
US20090068290A1 (en) *	2006-08-31	2009-03-12	Michel Bourin	Bifeprunox doses for treating schizophrenia
JP2011511011A (ja)	2008-02-05	2011-04-07	ハーバーバイオサイエンシーズ，インコーポレイテッド	医薬的固体状態形態
WO2011023796A1 (en)	2009-08-31	2011-03-03	Abbott Healthcare Products B.V.	Bifeprunox for treating addiction
UY32935A (es)	2009-10-12	2011-05-31	Abbott Healthcare Products Bv	Polimorfos de pardoprunox

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3586794T2 (de)	1984-12-21	1993-05-27	Duphar Int Res	Arzneimittel mit psychotroper wirkung.
EP0190472B1 (en) *	1984-12-21	1989-07-12	Duphar International Research B.V	New pharmaceutical compositions having anti-psychotic properties
JPH0344383A (ja) *	1989-07-12	1991-02-26	Ihara Chem Ind Co Ltd	５―トリフルオロメチル―２―ハロメチルベンゾチアゾール類の製造法
JP3044383B2 (ja) *	1990-05-22	2000-05-22	コニカ株式会社	含窒素６員環化合物の製造方法
TR199801942T2 (xx) *	1996-03-29	2000-08-21	Duphar International Research B.V.	Piperazin ve piperidin bile�ikleri.
SE9702799D0 (sv) *	1997-07-25	1997-07-25	Astra Ab	New compounds
UA71590C2 (en) *	1998-11-13	2004-12-15	Duphar Int Res	Piperazine and piperidine derivatives
US7435738B2 (en) *	2003-08-18	2008-10-14	Solvay Pharmaceuticals, Inc.	Stable crystalline form of bifeprunox mesylate (7-[4-([1,1′-biphenyl]-3-ylmethyl)-1-piperazinyl]-2(3H)-benzoxazolone monomethanesulfonate)

2002
- 2002-02-12 AR ARP020100460A patent/AR034206A1/es active IP Right Grant
- 2002-02-14 SI SI200230061T patent/SI1362040T1/xx unknown
- 2002-02-14 ME MEP-375/08A patent/MEP37508A/xx unknown
- 2002-02-14 SK SK309-2003A patent/SK286143B6/sk not_active IP Right Cessation
- 2002-02-14 IL IL153509A patent/IL153509A/en not_active IP Right Cessation
- 2002-02-14 DK DK02719858T patent/DK1362040T3/da active
- 2002-02-14 AT AT02719858T patent/ATE284875T1/de active
- 2002-02-14 UA UA2003098528A patent/UA75390C2/uk unknown
- 2002-02-14 CN CNB028016858A patent/CN1176079C/zh not_active Expired - Fee Related
- 2002-02-14 PL PL369330A patent/PL208363B1/pl unknown
- 2002-02-14 JP JP2002565965A patent/JP4328528B2/ja not_active Expired - Fee Related
- 2002-02-14 NZ NZ524632A patent/NZ524632A/en not_active IP Right Cessation
- 2002-02-14 DE DE60202261T patent/DE60202261T2/de not_active Expired - Lifetime
- 2002-02-14 MX MXPA03002359A patent/MXPA03002359A/es active IP Right Grant
- 2002-02-14 BR BR0205683-6A patent/BR0205683A/pt not_active Application Discontinuation
- 2002-02-14 EP EP02719858A patent/EP1362040B1/en not_active Expired - Lifetime
- 2002-02-14 CA CA2422703A patent/CA2422703C/en not_active Expired - Fee Related
- 2002-02-14 RS YUP-644/03A patent/RS51126B/sr unknown
- 2002-02-14 AU AU2002250962A patent/AU2002250962B2/en not_active Ceased
- 2002-02-14 KR KR1020087015071A patent/KR101000733B1/ko not_active IP Right Cessation
- 2002-02-14 MY MYPI20020505A patent/MY130687A/en unknown
- 2002-02-14 WO PCT/EP2002/001666 patent/WO2002066449A2/en active IP Right Grant
- 2002-02-14 ES ES02719858T patent/ES2230481T3/es not_active Expired - Lifetime
- 2002-02-14 HU HU0400772A patent/HUP0400772A3/hu unknown
- 2002-02-14 KR KR1020037000026A patent/KR100859106B1/ko not_active IP Right Cessation
- 2002-02-14 RU RU2003105902/04A patent/RU2272036C2/ru not_active IP Right Cessation
- 2002-02-14 DZ DZ023489A patent/DZ3489A1/fr active
- 2002-02-14 US US10/468,098 patent/US7030241B2/en not_active Expired - Fee Related
- 2002-02-14 PT PT02719858T patent/PT1362040E/pt unknown
- 2002-02-14 CZ CZ20030697A patent/CZ301780B6/cs not_active IP Right Cessation
2003
- 2003-02-26 ZA ZA200301590A patent/ZA200301590B/en unknown
- 2003-04-15 NO NO20031754A patent/NO324460B1/no not_active IP Right Cessation
- 2003-07-17 IS IS6876A patent/IS2417B/is unknown
- 2003-07-28 HR HR20030610A patent/HRP20030610B1/xx not_active IP Right Cessation
- 2003-08-13 BG BG108090A patent/BG66101B1/bg unknown
2004
- 2004-04-22 HK HK04102835A patent/HK1059934A1/xx not_active IP Right Cessation

Also Published As

Publication number	Publication date
IS2417B (is)	2008-10-15
DE60202261D1 (de)	2005-01-20
PT1362040E (pt)	2005-05-31
BR0205683A (pt)	2004-07-06
AU2002250962B2 (en)	2006-08-24
HRP20030610A2 (en)	2005-06-30
JP2004518741A (ja)	2004-06-24
HUP0400772A2 (hu)	2004-08-30
ZA200301590B (en)	2004-02-05
EP1362040B1 (en)	2004-12-15
US20040077631A1 (en)	2004-04-22
AR034206A1 (es)	2004-02-04
KR101000733B1 (ko)	2010-12-14
CN1463268A (zh)	2003-12-24
UA75390C2 (en)	2006-04-17
EP1362040A2 (en)	2003-11-19
IL153509A (en)	2007-12-03
NO324460B1 (no)	2007-10-22
IL153509A0 (en)	2003-07-06
CA2422703A1 (en)	2002-08-29
JP4328528B2 (ja)	2009-09-09
BG108090A (bg)	2004-12-30
HUP0400772A3 (en)	2008-02-28
SK3092003A3 (en)	2003-09-11
CZ301780B6 (cs)	2010-06-23
IS6876A (is)	2003-07-17
ES2230481T3 (es)	2005-05-01
DE60202261T2 (de)	2005-05-19
SI1362040T1 (en)	2005-06-30
HRP20030610B1 (en)	2006-02-28
PL369330A1 (en)	2005-04-18
WO2002066449A3 (en)	2002-10-24
DK1362040T3 (da)	2005-01-24
MY130687A (en)	2007-07-31
PL208363B1 (pl)	2011-04-29
KR20030077523A (ko)	2003-10-01
CZ2003697A3 (cs)	2003-06-18
RS51126B (sr)	2010-10-31
NO20031754D0 (no)	2003-04-15
ATE284875T1 (de)	2005-01-15
MEP37508A (en)	2011-02-10
CN1176079C (zh)	2004-11-17
NZ524632A (en)	2004-03-26
SK286143B6 (sk)	2008-04-07
US7030241B2 (en)	2006-04-18
HK1059934A1 (en)	2004-07-23
KR20080064206A (ko)	2008-07-08
KR100859106B1 (ko)	2008-09-18
CA2422703C (en)	2010-04-13
RU2272036C2 (ru)	2006-03-20
DZ3489A1 (fr)	2002-08-29
BG66101B1 (bg)	2011-04-29
MXPA03002359A (es)	2003-06-30
WO2002066449A2 (en)	2002-08-29
YU64403A (sh)	2006-05-25

Publication	Publication Date	Title
NO20030012L (no)	2003-03-03	Fremgangsmåte for fremstilling av substituerte oktanoylamider
NO20042680L (no)	2004-06-25	Fremgangsmater for fremstilling av O-demetylvenflaxine
NO20040278L (no)	2004-01-21	Fremgangsmate for fremstilling av perindopril
NO20031754L (no)	2003-04-15	Fremgangsmåte for fremstilling av mesylater av piperzinderivater
IL160043A0 (en)	2004-06-20	Process for the preparation of indole derivatives
FI20011889A (fi)	2003-03-27	Menetelmä ksylitolin valmistamiseksi
HUP0401600A3 (en)	2008-05-28	Process for the preparation of 14-hydroxymorphine derivatives
NO20044814L (no)	2004-01-07	Fremgangsmate for fremstilling av combretastaniner
NO20042640L (no)	2004-06-23	Fremgangsmate for fremstilling av ekinocandinderivater
NO20031413D0 (no)	2003-03-27	Ny fremgangsmåte for fremstilling av oksabispidiner
IL159304A0 (en)	2004-06-01	Process for the production of piperidine derivatives
NO20035586L (no)	2003-12-15	Fremgangsmate for fremstilling av cykloheksanol-derivater
IL158360A0 (en)	2004-05-12	Process for the preparation of 7-substituted 3-alkyl-3h-isobenzofuran-1-one derivatives
HUP0101875A3 (en)	2002-11-28	Process for the preparation of piperidine derivatives
IL165137A0 (en)	2005-12-18	Process for the preparation of thioalkylamine derivatives
NO20020059D0 (no)	2002-01-07	Fremgangsmåte for fremstilling av dibenzotiazepinderivater
NO20030515L (no)	2003-03-31	Fremgangsmåte for fremstilling av dinapsolin
NO20044332L (no)	2005-01-17	Forbedret fremgangsmate for fremstilling av nevirapine
NO20042202L (no)	2004-08-19	Fremgangsmate for fremstilling av asymmetriske karotenoider
IL162770A (en)	2011-06-30	Process for the preparation of 7??-methyl-estr-4-ene-3-one derivatives
FR2826004B1 (fr)	2008-03-28	Procede de preparation de derives estrogenes
NO20035138D0 (no)	2003-11-18	Fremgangsmåte til fremstilling av amorft natriumsilastatin
NO20032297L (no)	2003-05-21	Fremgangsmåte for fremstilling av distamycinderivater
NO20023702D0 (no)	2002-08-06	Fremgangsmåte for fremstilling av 5-arylnikotinaldehyder
NO20020328D0 (no)	2002-01-22	Fremgangsmåte for fremstilling av 4-cyano-2-aminometyltiazol

Legal Events

Date	Code	Title	Description
2013-09-30	MM1K	Lapsed by not paying the annual fees